Skip to main content
Clinical Trials/NCT03713034
NCT03713034CompletedNot Applicable

An Accessible Digital Intervention to Promote the Use of School-based Health Centers and to Empower Adolescents With Their Sexual Health

Yale University2 sites in 1 country296 target enrollmentStarted: November 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
296
Locations
2
Primary Endpoint
Attitudes Around HIV Testing and Counseling

Study Overview

Brief Summary

This is Phase II of a study previously registered on ClinicalTrials.gov (NCT02812329). Phase II focuses on adapting and expanding the reach of a previously developed video game aimed at HIV prevention. The game will be adapted to include web access/distribution and be evaluated using a randomized controlled trial.

Detailed Description

The specific aims for Phase II of this study are to:

Further adapt and expand our culturally and socially-tailored videogame to have a greater focus on HIV testing and counseling (HTC) in addition to HIV prevention in an older age group of 14-18 year old boys and girls.

This will be accomplished by refining the conceptual model of the theoretical mechanisms of behavior change to be applied specifically within the game. New content will be created with additional input from 4 focus groups of 5 adolescents each (n = 20, aged 14-18) and these participants will also play-test the game. In addition, this model will inform new intervention manuals ("Game Playbooks") targeting these new outcomes. Building the new content from focus groups into the game are intended to adapt and expand its scope.

A system will be established for the newly adapted game for web access/distribution and program integration. Work will continue with commercialization partners on widespread distribution of the adapted game.

The final piece of the study will be to conduct a randomized controlled trial in 296 adolescents (aged 14-18) to evaluate the acceptability and efficacy of the adapted game on its new web-based platform compared with a set of control games.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
14 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Ability to participate in a web-based videogame (willing to sit for 60 minutes/session to play the game)
  • Have not been tested for HIV in the past year
  • Ability to provide assent/parental/guardian consent+
  • Have a completed and signed enrollment form for their school's health clinic allowing them, if they choose, to access the clinic for testing and health care
  • Students can be older than 18 as long as they were 18 or younger at the time of signing consent

Exclusion Criteria

  • Failure to meet any of the eligibility criteria

Outcomes

Primary Outcomes

Attitudes Around HIV Testing and Counseling

Time Frame: Baseline, 4 weeks, 3 months and 6 months

HTC attitudes were assessed with 7 items (e.g., "I feel it is important for me to get tested for HIV"). The items were scored on a 5-point scale ranging from - 2 (strongly disagree) to +2 (strongly agree) with positive values indicating healthier attitudes towards HTC. Participants had the option to respond "not sure" which was given a neutral score of 0. A mean of the seven items was calculated for each participant. A few items were reverse coded, because the lower value was indicating healthier attitudes. Not sure was coded as a neutral option. Higher scores equal more positive attitudes toward HIV testing and counseling.

Secondary Outcomes

  • Number of Students Tested for HIV at Month 2(Month 2)
  • Number of Students Tested for HIV at Month 4(month 4)
  • Number of Students Tested for HIV at Month 5(Month 5)
  • Intentions to Get Tested for HIV(Baseline, 4 weeks, 3 months and 6 months)
  • Number of Students Tested for HIV at Month 1(Month 1)
  • Perceived Barriers to HIV Testing(6 months)
  • Self-efficacy Around HIV Testing and Counseling(Baseline, 4 weeks, 3 months, 6 months)
  • Number of Students Tested for HIV at Month 3(Month 3)
  • Number of Students Tested for HIV at Month 6(Month 6)
  • Self-efficacy Around Overall Health(Baseline, 4 weeks, 3 months, 6 months)
  • Knowledge About HTC(Baseline, 4 weeks, 3 months, 6 months)
  • HIV Testing and Counseling Behavior (Self-Report)(Baseline, 4 Weeks, 3 Months, 6 Months)
  • Perceived Barriers to STI Testing(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Terminated
Phase 2
A Study to Evaluate the Safety and Effectiveness of a Digital TherapeuticSuicide, AttemptedSuicidal Ideation
NCT05144685Oui Therapeutics, Inc.356
Terminated
Not Applicable
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Lung Non-Small Cell CarcinomaPrognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8
NCT04705025Jonsson Comprehensive Cancer Center5
Completed
Phase 2
Phase II trial (Investigator-initiated clinical trial) of CH5424802 in patients with relapsed or refractory ALK-positive anaplastic large cell lymphomaRelapsed or refractory ALK-positive anaplastic large cell lymphoma
JPRN-UMIN000016991ational Hospital Organization Nagoya Medical Center Hirokazu Nagai St.Marianna University School of Medicine Hospital Tetsuya Mori National Hospital Oganization Kyusyu cancer center Che Irusun10
Completed
Not Applicable
Digital Health Intervention to Support Opioid Use Disorder TreatmentOpioid Use DisorderTreatment Adherence
NCT03842384Rhode Island Hospital80
Recruiting
Phase 3
An SCT-based digital intervention among type 2 diabetes mellitus patients: an open-label randomized controlled trialDiabetes Type 2
JPRN-jRCT2032220603Waki Kayo160